Entera Bio Ltd (ENTX) Social Stream

Entera Bio Ltd (ENTX): $2.61

-0.23 (-8.10%)

POWR Rating

Component Grades













Add ENTX to Watchlist
Sign Up

Industry: Biotech


of 481

in industry

Entera Bio Ltd (ENTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Entera Bio Ltd.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $12 $10 $11 $2.73 302.93%

The Trend in the Analyst Price Target

Over the past 131 days, ENTX's average price target has gone down $1.

Over the past 49 weeks, ENTX's average upside potential has been 173.77%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-06 2 12 10 11 2.76 298.55%
2021-06-26 2 14 10 12 5.97 101.01%
2021-01-30 NA 5 5 5 1.46 242.47%

ENTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations

Over the past 44 weeks, ENTX's average broker recommendation rating improved by 1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Entera Bio Ltd's number of analysts covering the stock is higher than 5.5% of Pharmaceutical Products stocks.
  • Entera Bio Ltd's variance in analysts' estimates is lower than 83.56% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, Entera Bio Ltd's average analyst price target is higher than 18.8% of them.
  • In the context of Healthcare stocks, Entera Bio Ltd's upside potential (average analyst target price relative to current price) is greater than 78.67% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Entera Bio Ltd are CAPR, FLGC and INMB.

Is ENTX a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 2.1193 seconds.